vivotif ≥ 2x10e9 cfu kapsułki dojelitowe
bavarian nordic a/s - Żywe komórki salmonella enterica serowar typhi ty21a - kapsułki dojelitowe - ≥ 2x10e9 cfu
nurofen mięśnie i stawy 200 mg plaster leczniczy
reckitt benckiser (poland) s.a. - ibuprofenum - plaster leczniczy - 200 mg
idefirix
hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - leki immunosupresyjne - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.
enhertu
daiichi sankyo europe gmbh - trastuzumab deruxtecan - nowotwory piersi - Środki przeciwnowotworowe - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.
shango
proeuro sp. z o.o. stary rynek, 65-067 zielona góra - aklonifen - 600 g - chwastobójczy
diklofenak toppharm 10 mg/g Żel
herbacos recordati s.r.o. - diclofenacum natricum - Żel - 10 mg/g
trodelvy
gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - Środki przeciwnowotworowe - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.
xevudy
glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - odporne surowicy i immunoglobuliny, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.
upstaza
ptc therapeutics international limited - eladocagene exuparvovec - metabolizm aminokwasowy, wrodzone błędy - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.
zynlonta
swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - Środki przeciwnowotworowe - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.